Ashley Hume is a 25-year veteran in the health care and managed care industries, bringing extensive experience leading multidisciplinary teams in both the provider and payer spaces. As the President of Emerging Therapy Solutions (ETS), Ashley oversees all aspects of the organization, driving strategic initiatives related to cost containment and risk projection for catastrophic claims. She also manages client-facing teams and market strategy. Ashley sits on multiple national committees focused on reimbursement policy and innovative payment strategies for cell & gene therapy. Prior to ETS, Ashley held leadership positions at a health plan and a health plan services company. She also held senior leadership positions over revenue cycle and contracting for large specialty groups and a health system, gaining significant expertise in prior authorization, claims and patient financial services, as well as in third-party payor, direct-to-employer, and physician services contracting.